208 related articles for article (PubMed ID: 11260097)
1. Preoperative (neoadjuvant) chemoradiotherapy in oesophageal cancer.
Geh JI; Crellin AM; Glynne-Jones R
Br J Surg; 2001 Mar; 88(3):338-56. PubMed ID: 11260097
[TBL] [Abstract][Full Text] [Related]
2. Preoperative concurrent chemotherapy and radiation therapy followed by surgery for esophageal cancer.
Yano M; Inoue M; Shiozaki H
Ann Thorac Cardiovasc Surg; 2002 Jun; 8(3):123-30. PubMed ID: 12472392
[TBL] [Abstract][Full Text] [Related]
3. Impact of preoperative radiochemotherapy on postoperative course and survival in patients with locally advanced squamous cell oesophageal carcinoma.
Mariette C; Piessen G; Lamblin A; Mirabel X; Adenis A; Triboulet JP
Br J Surg; 2006 Sep; 93(9):1077-83. PubMed ID: 16779882
[TBL] [Abstract][Full Text] [Related]
4. Myelotoxicity of preoperative chemoradiotherapy is a significant determinant of poor prognosis in patients with T4 esophageal cancer.
Miyoshi N; Yano M; Takachi K; Kishi K; Noura S; Eguchi H; Yamada T; Miyashiro I; Ohue M; Ohigashi H; Sasaki Y; Ishikawa O; Doki Y; Imaoka S
J Surg Oncol; 2009 Apr; 99(5):302-6. PubMed ID: 19170110
[TBL] [Abstract][Full Text] [Related]
5. Only pathologic complete response to neoadjuvant chemotherapy improves significantly the long term survival of patients with resectable esophageal squamous cell carcinoma: final report of a randomized, controlled trial of preoperative chemotherapy versus surgery alone.
Ancona E; Ruol A; Santi S; Merigliano S; Sileni VC; Koussis H; Zaninotto G; Bonavina L; Peracchia A
Cancer; 2001 Jun; 91(11):2165-74. PubMed ID: 11391598
[TBL] [Abstract][Full Text] [Related]
6. The effectiveness of planned esophagectomy after neoadjuvant chemoradiotherapy for advanced esophageal carcinomas.
Kato H; Fukuchi M; Manda R; Faried A; Takita J; Nakajima M; Miyazaki T; Sohda M; Fukai Y; Masuda N; Tsukada K; Kuwano H
Anticancer Res; 2004; 24(6):4091-6. PubMed ID: 15736457
[TBL] [Abstract][Full Text] [Related]
7. [Chemoradiotherapy followed by surgery in treatment of locally advanced esophageal carcinoma: a phase II trial].
Fu JH; Rong TH; Li XD; Hu Y; Ou W; Hu YH; Li Q
Ai Zheng; 2004 Nov; 23(11 Suppl):1473-6. PubMed ID: 15566661
[TBL] [Abstract][Full Text] [Related]
8. Systematic overview of preoperative (neoadjuvant) chemoradiotherapy trials in oesophageal cancer: evidence of a radiation and chemotherapy dose response.
Geh JI; Bond SJ; Bentzen SM; Glynne-Jones R
Radiother Oncol; 2006 Mar; 78(3):236-44. PubMed ID: 16545878
[TBL] [Abstract][Full Text] [Related]
9. Neoadjuvant therapy of esophageal cancer.
Ilson DH; Bains M; Ginsberg RJ; Kelsen DP
Surg Oncol Clin N Am; 1997 Oct; 6(4):723-40. PubMed ID: 9309090
[TBL] [Abstract][Full Text] [Related]
10. [Value of radiotherapy and chemotherapy in treatment of operable cancers of the esophagus].
Msika S; Hay JM
J Chir (Paris); 2002 Feb; 139(1):17-24. PubMed ID: 12071024
[TBL] [Abstract][Full Text] [Related]
11. Improved local control by surgery and paclitaxel-based chemoradiation for esophageal squamous cell carcinoma: results of a retrospective non-randomized study.
Hsu FM; Lin CC; Lee JM; Chang YL; Hsu CH; Tsai YC; Lee YC; Cheng JC
J Surg Oncol; 2008 Jul; 98(1):34-41. PubMed ID: 18449912
[TBL] [Abstract][Full Text] [Related]
12. Neoadjuvant therapy for esophageal cancer: standard of care or elusive myth?
Boyle MJ; Franceschi D; Robinson DS; Livingstone AS
Am Surg; 2001 Oct; 67(10):956-65. PubMed ID: 11603553
[TBL] [Abstract][Full Text] [Related]
13. Multimodal therapy for squamous carcinoma of the oesophagus.
Lehnert T
Br J Surg; 1999 Jun; 86(6):727-39. PubMed ID: 10383570
[TBL] [Abstract][Full Text] [Related]
14. Neoadjuvant chemoradiotherapy for resectable oesophageal and gastro-oesophageal junction cancer--do we need another randomised trial?
Hingorani M; Crosby T; Maraveyas A; Dixit S; Bateman A; Roy R
Clin Oncol (R Coll Radiol); 2011 Dec; 23(10):696-705. PubMed ID: 21684129
[TBL] [Abstract][Full Text] [Related]
15. Esophageal cancer: adjuvant therapy.
Ku GY; Ilson DH
Cancer J; 2007; 13(3):162-7. PubMed ID: 17620765
[TBL] [Abstract][Full Text] [Related]
16. Multimodality treatment for esophageal cancer: the role of surgery and neoadjuvant therapy.
Makary MA; Kiernan PD; Sheridan MJ; Tonnesen G; Hetrick V; Vaughan B; Graling P; Elster E
Am Surg; 2003 Aug; 69(8):693-700; discussion 700-2. PubMed ID: 12953828
[TBL] [Abstract][Full Text] [Related]
17. Use of oesophagogastroscopy to assess the response of oesophageal carcinoma to neoadjuvant therapy.
Brown WA; Thomas J; Gotley D; Burmeister BH; Lim KH; Martin I; Walpole ET; Thomson DB; Harvey JA; Smithers BM
Br J Surg; 2004 Feb; 91(2):199-204. PubMed ID: 14760668
[TBL] [Abstract][Full Text] [Related]
18. Pretreatment T3-4 stage is an adverse prognostic factor in patients with esophageal squamous cell carcinoma who achieve pathological complete response following preoperative chemoradiotherapy.
Chao YK; Chan SC; Liu YH; Chen HW; Wan YL; Chang HK; Fan KH; Liu HP
Ann Surg; 2009 Mar; 249(3):392-6. PubMed ID: 19247024
[TBL] [Abstract][Full Text] [Related]
19. Preoperative therapy in esophageal cancer.
Ku GY; Ilson DH
Clin Adv Hematol Oncol; 2008 May; 6(5):371-9. PubMed ID: 18516027
[TBL] [Abstract][Full Text] [Related]
20. Neoadjuvant chemoradiotherapy for locally advanced esophageal cancer: experience at a single institution.
Malaisrie SC; Untch B; Aranha GV; Mohideen N; Hantel A; Pickleman J
Arch Surg; 2004 May; 139(5):532-8; discussion 538-9. PubMed ID: 15136354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
